TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM
$3.71B
1-Year Return
19.93%
This Quarter Return
-13.85%
1 Year Return
+19.93%
3 Year Return
+90.1%
5 Year Return
+158.53%
10 Year Return
+284.02%
AUM
$1.39B
AUM Growth
+$23.5M
(+1.7%)
Cap. Flow
+$193M
Cap. Flow
% of AUM
13.94%
Top 10 Holdings %
Top 10 Hldgs %
24.95%
Holding
4,841
New
1,002
Increased
1,367
Reduced
1,471
Closed
911
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
+$110M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$44.3M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$42.3M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
+$22.9M |
| 5 |
SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$19.5M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$115M |
| 2 |
iShares US Real Estate ETF
IYR
|
+$27.6M |
| 3 |
Energy Select Sector SPDR Fund
XLE
|
+$26.3M |
| 4 |
iShares Russell 3000 ETF
IWV
|
+$22M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$14M |
Sector Composition
| 1 | Healthcare | 6.26% |
| 2 | Financials | 5.86% |
| 3 | Technology | 5.04% |
| 4 | Energy | 4.86% |
| 5 | Consumer Discretionary | 4.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Invesco FTSE RAFI US 1000 ETF
PRF
$8.18B
| $51K | ﹤0.01% |
2,505
+2,500
| +50,000% | +$50.9K |
|
|
TCF
1277
DELISTED
TCF Financial Corporation Common Stock
TCF
| $51K | ﹤0.01% |
1,397
-6,255
| -82% | -$228K |
|
|
HIFR
1278
DELISTED
InfraREIT, Inc.
HIFR
| $51K | ﹤0.01% |
2,429
+2,274
| +1,467% | +$47.7K |
|
|
ALX
1279
Alexander's
ALX
$1.25B
| $50K | ﹤0.01% |
+165
| New | +$50K |
|
1280
Commerce Bancshares
CBSH
$7.95B
| $50K | ﹤0.01% |
1,202
-13,107
| -92% | -$545K |
|
1281
Crawford & Co Class B
CRD.B
$494M
| $50K | ﹤0.01% |
5,640
-908
| -14% | -$8.05K |
|
1282
Ecopetrol
EC
$18.8B
| $50K | ﹤0.01% |
3,131
-2,565
| -45% | -$41K |
|
1283
Galicia Financial Group
GGAL
$4.81B
| $50K | ﹤0.01% |
1,817
-4,551
| -71% | -$125K |
|
1284
Great Southern Bancorp
GSBC
$710M
| $50K | ﹤0.01% |
+1,079
| New | +$50K |
|
1285
Kinross Gold
KGC
$28.4B
| $50K | ﹤0.01% |
15,479
+6,659
| +75% | +$21.5K |
|
1286
Landstar System
LSTR
$4.46B
| $50K | ﹤0.01% |
524
-947
| -64% | -$90.4K |
|
1287
Monroe Capital Corp
MRCC
$165M
| $50K | ﹤0.01% |
+5,166
| New | +$50K |
|
1288
National Healthcare
NHC
$1.78B
| $50K | ﹤0.01% |
+635
| New | +$50K |
|
1289
Potbelly
PBPB
$514M
| $50K | ﹤0.01% |
6,121
+4,125
| +207% | +$33.7K |
|
1290
Ultrapar
UGP
$4.1B
| $50K | ﹤0.01% |
7,358
-3,362
| -31% | -$22.8K |
|
1291
Vital Energy
VTLE
$635M
| $50K | ﹤0.01% |
685
+139
| +25% | +$10.1K |
|
1292
John Wiley & Sons Class A
WLY
$2.19B
| $50K | ﹤0.01% |
1,049
-2,380
| -69% | -$113K |
|
|
SYRS
1293
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $50K | ﹤0.01% |
913
+811
| +795% | +$44.4K |
|
1294
DTE Energy
DTE
$28.4B
| $49K | ﹤0.01% |
522
-6,957
| -93% | -$653K |
|
1295
First Trust SSI Strategic Convertible Securities ETF
FCVT
$93.9M
| $49K | ﹤0.01% |
+1,770
| New | +$49K |
|
1296
Rayonier
RYN
$4.05B
| $49K | ﹤0.01% |
1,867
-8,567
| -82% | -$225K |
|
|
SABA
1297
Saba Capital Income & Opportunities Fund II
SABA
$255M
| $49K | ﹤0.01% |
4,030
+2,535
| +170% | +$30.8K |
|
1298
Sensata Technologies
ST
$4.55B
| $49K | ﹤0.01% |
1,095
-7,942
| -88% | -$355K |
|
1299
Sutro Biopharma
STRO
$74.3M
| $49K | ﹤0.01% |
+5,518
| New | +$49K |
|
1300
Toll Brothers
TOL
$13.8B
| $49K | ﹤0.01% |
1,491
-10,618
| -88% | -$349K |
|